From Innovation to Impact: Growing Globally Competitive Innovation Ecosystems in the New Realities of 2026

2026 will be marked by new risks and opportunities. Across Europe, innovation ecosystems–from research hubs and TTOs to trade agencies, accelerators, and investors–will need to navigate a new era of regulatory shifts, tighter economics, and fierce global competition. This session explores what practical readiness will look like in 2026 for medtech, biotech, and digital health portfolios expanding internationally. 

Join this strategic debrief to hear:

• What the Draghi report may have not foreseen
• Real world case studies from across the EU in healthtech innovation that have informed a framework for overcoming the next wave of internationalisation challenges
• New and emerging opportunities to collaborate with US industry, investors, talent, and researchers–while retaining R&D and jobs at home
• What changes in the US healthcare landscape will impact commercial opportunities

Drawing on examples from the Nordics, Baltics, Central and Western Europe, we’ll examine what’s working, what’s unlikely to succeed in the future, and how European innovation can leverage these changes to succeed in 2026.

Participants will receive complimentary access to the 2026 Internationalisation Readiness Roadmap workshop, a candid course for healthtech leaders in which actionable insights, frameworks, and tools will be shared to understand which evolving global policy and commercial factors are the most impactful to watch, how to de-risk plans in uncertain times, and opportunities amid the changing landscape.